Smartlens is a clinical stage medical technology company with a vision of preventing blindness due to Glaucoma. Beginning as a Stanford University research project, Smartlens has developed an accurate, electronics free and affordable soft contact lens capable of measuring intraocular pressure (IOP), the primary risk factor and indicator of Glaucoma. As the leading cause of irreversible blindness worldwide, Glaucoma is a very difficult condition to diagnose, treat, and monitor. Our contact lens provides an efficient and convenient way of monitoring IOP at home.
With its strong IP, Smartlens has the unique opportunity to intervene and prevent Glaucoma-related blindness and significantly improve how doctors manage the disease with frequent IOP measurements. At Smartlens, we envision a world where Glaucoma can’t rob people of their vision and quality of life.